课题基金 / 基金详情

Differential interaction of CrkII adaptor protein with plateletderived growth factor alpha-and beta-receptors is determined bu its internal tyrosine phosphorylation

Differential interaction of CrkII adaptor protein with plateletderived growth factor alpha-and beta-receptors is determined bu its internal tyrosine phosphorylation
CrkII 衔接蛋白与血小板源性生长因子 α 和 β 受体的差异相互作用是通过其内部酪氨酸磷酸化来确定的
批准号:
11838002
负责人:
MORI Seijiro
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MORI Seijiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CrkII is an intracellular adaptor protein involved in signal transduction by various growth factors. Activation of PDGF alpha-receptor resulted in its association with CrkII in vivo. In contrast, binding of CrkII to the PDGF beta-receptor was negligible, despite its becoming prominently phosphorylated. Bacterially expressed GST-CrkII SH2 domain specifically bound to Tyr-762 and Tyr-771 in the activated PDGF alpha-and beta-receptors, respectively. GST fusion protein of full-length CrkII also bound to the activated PDGF beta-receptor. However, tyrosine phosphorylation of GST-CrkII diminished its binding to the beta-receptor. CrkI, a truncated version of CrkII lacking the phosphorylatable tyrosine residue, could bind to both PDGF alpha-and beta-receptors in vivo. In conclusion, tyrosine phosphorylation of CrkII negatively affects its binding to the PDGF receptors. The differential binding of CrkII to the PDGF alpha-and beta-receptors may be a rationale for functional diversity between the two receptors.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Matsumoto, T et al: "Differential interaction of CrkII adaptor protein with platelet-derived growth factor alpha-and beta-receptor is determined by its internal tyrosine phosphorylation."Biochemical and biophysical Research communications. 270. 28-33 (200
Matsumoto, T 等人:“CrkII 衔接蛋白与血小板衍生生长因子 α 和 β 受体的不同相互作用是由其内部酪氨酸磷酸化决定的。”生物化学和生物物理研究通讯。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Minoru Takemoto: "Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells"Biochem. Biophys. Res. Commun.. 258. 722-726 (1999)
Minoru Takemoto:“培养的大鼠主动脉平滑肌细胞中高葡萄糖增强骨桥蛋白的表达”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Taro M.Itsumoto, et al: "Differential interaction of Crkll adapter protein with platelet-derived growth factor alpha- and beta-receptors is determined by its internal tyrosine phosphorylation"Biochemical and Biophysical Research Communications. 270. 28-33
Taro M.Itsumoto 等人:“CrkII 衔接蛋白与血小板衍生生长因子 α 和 β 受体的差异相互作用是由其内部酪氨酸磷酸化决定的”《生物化学和生物物理研究通讯》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Taro Matsumoto,Seijiro Mori, et al: "Differential interaction of Crkll adapter protein with platelet-derived growth factor alpha-and beta-receptors is determined by its internal tyrosine phosphorylation"Biochemical and Biophysical Research Communications.
Taro Matsumoto、Seijiro Mori 等人:“Crkll 接头蛋白与血小板衍生生长因子 α 和 β 受体的差异相互作用是由其内部酪氨酸磷酸化决定的”生物化学和生物物理研究通讯。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ligand-induced Ubiquitination of Receptor Tyrosine Kinases
  • 批准号:
    10044239
  • 项目类别:
    Grant-in-Aid for international Scientific Research
  • 资助金额:
    $0.83万
  • 财政年份:
    1998
  • 负责人:
    MORI Seijiro
  • 依托单位:
Structural and functional analysis of ligand-induced polyubiquitination of platelet-derived growth factor receptor
  • 批准号:
    07557222
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $0.64万
  • 财政年份:
    1995
  • 负责人:
    MORI Seijiro
  • 依托单位:
国内基金
海外基金
拟南芥受体激酶CRK45调控植物耐砷分子机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
祛邪胶囊调控Crk-Rac信号通路抑制结直肠癌侵袭的机制研究
BDNF基因通过miR-146b/CRK调节膀胱癌细胞PD-L1表达及免疫逃逸
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
  • 依托单位:
HSP110DE9抑制Crk依赖性CD8+T细胞衰竭在MSS型结直肠癌中抗PD-1免疫治疗增敏作用的研究
  • 批准号:
    82160547
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    34万元
  • 批准年份:
    2021
  • 负责人:
    高嫦娥
  • 依托单位: